Mary Thistle is of Vigil Neuroscience, Inc.. Currently has a direct ownership of 5,000 shares of VIGL, which is worth approximately $39,950. The most recent transaction as insider was on May 22, 2025, when has been sold 5,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
n/a 3M change
n/a 12M change
Total Value Held $39,950

Mary Thistle Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2025
BUY
Grant, award, or other acquisition
-
5,000 Added 50.0%
5,000 Common Stock

Also insider at

TCRT
Alaunos Therapeutics, Inc. Healthcare
FIXX
Homology Medicines, Inc. Healthcare
TRDA
Entrada Therapeutics, Inc. Healthcare
CGEM
Cullinan Oncology, Inc. Healthcare
MT

Mary Thistle

Boston, MA

Track Institutional and Insider Activities on VIGL

Follow Vigil Neuroscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIGL shares.

Notify only if

Insider Trading

Get notified when an Vigil Neuroscience, Inc. insider buys or sells VIGL shares.

Notify only if

News

Receive news related to Vigil Neuroscience, Inc.

Track Activities on VIGL